The NK cell receptor repertoire: Formation, adaptation and exploitation

Current Opinion in Immunology

Volumn 15, Issue 2, 2003, Pages 233-237

  Held, Werner ^a   Coudert, Jérôme D ^a   Zimmer, Jacques ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR;

CELL ACTIVATION; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NONHUMAN; REVIEW;

EID: 0037375569     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(02)00031-6     Document Type: Review

References (58)

1. Ljunggren H.G., Kärre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today. 11:1990;237-244.
2. Diefenbach A., Raulet D.H. Strategies for target cell recognition by natural killer cells. Immunol. Rev. 181:2001;170-184.
3. Cooper M.A., Fehniger T.A., Caligiuri M.A. The biology of human natural killer cell subsets. Trends Immunol. 22:2001;633-640.
4. Kim S., Iizuka K., Kang H.-S.P., Dokun A., French A.R., Greco D., Yokoyama W.M. In vivo developmental stages in murine natural killer cell maturation. Nat. Immunol. 3:2002;523-528 This paper proposes distinct stages of NK cell development based on phenotypic (differential expression of adhesion molecules) and functional properties. In addition, bone marrow NK cells are shown to undergo a phase of intense proliferation.
5. Corral L., Hanke T., Vance R.E., Cado D., Raulet D.H. NK cell expression of the killer cell lectin-like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules. Eur. J. Immunol. 30:2000;920-930.
6. Colonna M. Immunoglobulin superfamily inhibitory receptors: from natural killer cells to antigen-presenting cells. Res. Immunol. 148:1997;169-171.
7. + IL-2-activated natural killer cells. Nature. 358:1992;66-70.
8. Braud V.M., Allen D.S.J., O'Callaghan C.A., Söderström K., D'Andrea A., Ogg G.S., Lazetic S., Young N.T., Bell J.I., Phillips J.H.et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 391:1998;795-799.
9. Vance R.E., Kraft J.R., Altman J.D., Jensen P.E., Raulet D.H. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J. Exp. Med. 188:1998;1841-1848.
10. Lanier L.L., Corliss B.C., Wu J., Leong C., Phillips J. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature. 391:1998;703-707.
11. Raulet D.H., Vance R.E., McMahon C.W. Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol. 19:2001;291-330.
12. Borrego F., Kabat J., Kim D.-K., Lieto L., Maasho K., Pena J., Solana R., Coligan J.E. Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells. Mol. Immunol. 38:2001;637-660.
13. Nakamura M.C., Naper C., Niemi E.C., Spusta S.C., Rolstad B., Butcher G.W., Seaman W.E., Ryan J.C. Natural killing of xenogeneic cells mediated by the mouse Ly-49D receptor. J. Immunol. 163:1999;4694-4700.
14. Idris A.H., Smith H.R.C., Mason L.H., Ortaldo J., Scalzo A.A., Yokoyama W.M. The natural killer gene complex genetic locus Chok encodes Ly-49D, a target recognition receptor that activates natural killing. Proc. Natl. Acad. Sci. U.S.A. 96:1999;6330-6335.
15. Furukawa H., Iizuka K., Poursine-Laurent J., Shastri N., Yokoyama W.M. A ligand for the murine NK activation receptor Ly-49D: activation of tolerized NK cells from β2-microglobulin-deficient mice. J. Immunol. 169:2002;126-136 The authors present a demonstration that the Chinese hamster classical MHC class I molecule, Hm1-C4, is a ligand for the murine activating NKR, Ly49D. This explains the killing of the xenogeneic Chinese hamster ovary cell line CHO by murine NK cells through a Ly49D-dependent mechanism [13,14].
16. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science. 296:2002;1323-1326 Using an elegant reporter gene assay, this paper demonstrates the interaction of a virus-encoded molecule with an activating NK cell receptor. The MHC-like protein m157 encoded by MCMV binds to the activating receptor Ly49H. Indeed, Ly49H expression (e.g. in C57BL/6 mice) correlates with low virus titers in the spleens of MCMV-infected mice. In certain mouse strains, Ly49H is not expressed (e.g. BALB/c) or m157 binds to an allelic form of the inhibitory NK cell receptor Ly49I (e.g. 129/J). These latter cases correlate with high MCMV titers in infected mice.
17. ••], this paper demonstrates that m157 is a ligand for Ly49H. Furthermore, it shows that in vivo Ly49H is downmodulated upon ligand encounter.
18. Uhrberg M., Parham P., Wernet P. Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics. 54:2002;221-229.
19. Makrigiannis A.P., Pau A.T., Schwartzenberg P.L., McVicar D.W., Beck T.W., Anderson S.K. A BAC contig map of the Ly49 gene cluster in 129 mice reveals extensive differences in gene content relative to C57BL/6 mice. Genomics. 79:2002;437-444.
20. Uhrberg M., Valiante N.M., Shum B.P., Shilling H.G., Lienert-Weidenbach K., Corliss B., Tyan D., Lanier L.L., Parham P. Human diversity in killer cell inhibitory receptor genes. Immunity. 7:1997;753-763.
21. Kubota A., Kubota S., Lohwasser S., Mager D.L., Takei F. Diversity of NK cell receptor repertoire in adult and neonatal mice. J. Immunol. 163:1999;212-216.
22. + T cells. Proc. Natl. Acad. Sci. U.S.A. 95:1998;1172-1177.
23. Toomey J.A., Salcedo M., Cotterill L.A., Millrain M.M., Chrzanowska-Lightowlers Z., Lawry J., Fraser K., Gays F., Robinson J.H., Shrestha S.et al. Stochastic acquisition of Qa1 receptors during the development of fetal NK cells in vitro accounts in part but not in whole for the ability of these cells to distinguish between class I-sufficient and class I-deficient targets. J. Immunol. 163:1999;3176-3184.
24. - cells from multipotential murine bone marrow progenitors in a stroma-free culture: definition of cytokine requirements and developmental intermediates. J. Exp. Med. 186:1997;1609-1614.
25. Williams N.S., Kubota A., Bennett M., Kumar V., Takei F. Clonal analysis of NK cell development from bone marrow progenitors in vitro: orderly acquisition of receptor gene expression. Eur. J. Immunol. 30:2000;2074-2082.
26. Roth C., Carlyle J., Takizawa H., Raulet D.H. Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC. Immunity. 13:2000;143-153.
27. - progenitor cells require IL-15 (or IL-2) and contact with a murine fetal liver cell line to acquire CD94 and KIR expression. Single precursors give rise to NK cells with a diverse receptor repertoire, whereby certain KIRs (such as KIR2DL2/L3/S2) are over-represented.
28. Petrie H.T., Livak F., Schatz D.G., Strasser A., Crispe I.N., Shortman K. Multiple rearrangements in T cell receptor alpha chain genes maximize the production of useful thymocytes. J. Exp. Med. 178:1993;615-622.
29. + thymocytes. Nat. Immunol. 3:2002;469-476.
30. Held W., Kunz B., Ioannidis V., Lowin-Kropf B. Mono-allelic Ly49 NK cell receptor expression. Semin. Immunol. 11:1999;349-355.
31. Tanamachi D.M., Hanke T., Takizawa H., Jamieson A.M., Raulet D.H. Expression of natural killer receptor alleles at different Ly49 loci occurs independently and is regulated by major histocompatibility complex class I molecules. J. Exp. Med. 193:2001;307-315.
32. Held W., Kunz B., Lowin-Kropf B., van de Wetering M., Clevers H. Clonal acquisition of the Ly49A NK cell receptor is dependent on the trans-acting factor TCF-1. Immunity. 11:1999;433-442.
33. Kunz B., Held W. Positive and negative roles of the trans-acting factor TCF-1 for the acquisition of distinct Ly49 MHC class I receptors by NK cells. J. Immunol. 166:2001;6181-6187.
34. Santourlidis S., Trompeter H.-I., Weinhold S., Eisermann B., Meyer K.L., Wernet P., Uhrberg M. Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells. J. Immunol. 169:2002;4253-4261 A demonstration that expressed KIR genes are demethylated, whereas silenced ones are methylated. Importantly, demethylation in vitro, using 5-azacytidine, results in de novo KIR gene expression.
35. Ferrone S., Marincola F.M. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol. Today. 16:1995;487-494.
36. Cohen G.B., Gandhi R.T., Davis D.M., Mandelboim O., Chen B.K., Strominger J.L., Baltimore D. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity. 10:1999;661-671.
37. Huard B., Früh K. A role for MHC class I down-regulation in NK cell lysis of herpes virus-infected cells. Eur. J. Immunol. 30:2000;509-515.
38. Ohlen C., Kling G., Höglund P., Hansson M., Scangos G., Bieberich C., Jay G., Kärre K. Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice. Science. 246:1989;666-668.
39. + Natural Killer (NK) cells precludes ligand uptake from environmental cells: implications for NK cell function. J. Exp. Med. 194:2001;1531-1539.
40. Tormo J., Natarajan K., Margulies D.H., Mariuzza R.A. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature. 402:1999;623-631.
41. •].
42. •] analyze the adaptation of the Ly49 receptor repertoire in mice transgenic for Ly49C and/or Ly49A. They show that MHC class I engagement by a transgenic Ly49 receptor limits the expression of endogenous Ly49 receptors, irrespective of their MHC class I specificity. These findings are in agreement with sequential receptor acquisition and continuous adaptation to self-MHC class I, which, as one consequence, limits further receptor acquisition.
43. Liao N., Bix M., Zijlstra M., Jaenisch R., Raulet D. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science. 253:1991;199-202.
44. Zimmer J., Donato L., Hanau D., Cazenave J.P., Tongio M.M., Moretta A., de la Salle H. Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). J. Exp. Med. 187:1998;117-122.
45. Lowin-Kropf B., Kunz B., Schneider P., Held W. A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors. Eur. J. Immunol. 32:2002;773-782 NK cell activation by normal missing-self target cells depends in part on the src family kinase fyn. Fyn-deficient NK cells show reduced Ly49 receptor usage.
46. Colucci F., Schweighofer E., Tomasello E., Turner M., Ortaldo J.R., Vivier E., Tybulewicz L.J., Di Santo J.P. Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases. Nat. Immunol. 3:2002;288-294 This paper shows that activation pathways using NKG2D and the ITAM-binding molecules Syk/ZAP-70 are not required for killing normal missing-self target cells. In this case, Ly49 receptor usage is unperturbed.
47. - progenitors into NK cells, activation receptors, such as NKp46 and NKp30, are expressed before HLA class I-specific inhibitory receptors, raising the question of how tolerance is ensured. Interestingly, in immature NK cells, 2B4 may function as an inhibitory receptor and not as a co-receptor for NK cell activation (see also [48]).
48. Sivori S., Parolini S., Falco M., Marcenaro E., Biassoni R., Bottino C., Moretta L., Moretta A. 2B4 functions as a co-receptor in human NK cell activation. Eur. J. Immunol. 30:2000;787-793.
49. Morra M., Howie D., Grande M.S., Sayos J., Wang N., Wu C., Engel P., Terhorst C. X-linked lymphoproliferative disease: a progressive immunodeficiency. Annu. Rev. Immunol. 19:2001;657-682.
50. Wang J.-W., Howson J.M., Ghansah T., Desponts C., Ninos J.M., May S.L., Nguyen K.H.T., Toyamam-Sorimachi N., Kerr W.G. Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation. Science. 295:2002;2094-2097 This paper shows that certain Ly49-defined NK cell subsets expand over time in the absence of SHIP.
51. Moretta L., Ciccone E., Moretta A., Höglund P., Ohlen C., Kärre K. Allorecognition by NK cells: nonself or no self? Immunol. Today. 13:1992;300-306.
52. Ruggeri L., Capanni M., Urbani E., Perruccio K., Shlomchik W.D., Tosti A., Posati S., Rogaia D., Frassoni F., Aversa F.et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 295:2002;2097-2100 This paper greatly extends the authors previous data [53]. Haploidentical bone marrow transplantation (the critical point is, in fact, that one haplotype is not identical) allows for NK cell alloreactivity in the donor versus recipient direction. That feature very favorably influences engraftment and the control of acute myeloid leukemia in the recipient. Mouse experiments indeed suggest that alloreactive NK cells have not only a graft versus leukemia (GvL) effect (no relapse) but also eliminate the recipient's T cells (no graft rejection) and dendritic cells (no recipient antigen presentation to donor T cells and thus no GvHD).
53. Ruggeri L., Capanni M., Casucci M., Volpi I., Tosti A., Perruccio K., Urbani E., Negrin R.S., Martelli M.F., Velardi A. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood. 94:1999;333-339.
54. Wu M.-F., Raulet D.H. Class I-deficient hemopoietic cells and nonhemopoietic cells dominantly induce unresponsiveness of natural killer cells to class I-deficient bone marrow cell grafts. J. Immunol. 158:1997;1628-1633.
55. Kung S.K., Miller R.G. Mouse natural killer subsets defined by their target specificity and their ability to be separately rendered unresponsive in vivo. J. Immunol. 158:1997;2616-2626.
56. Johansson M.H., Bieberich C., Jay G., Kärre K., Höglund P. Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex class I molecules. J. Exp. Med. 186:1997;353-364.
57. Ioannidis V., Zimmer J., Beermann F., Held W. Cre recombinase-mediated inactivation of H-2Dd transgene expression: evidence for partial missing-self recognition by Ly49A NK cells. J. Immunol. 167:2001;6256-6262.
58. Bix M., Liao N.-S., Zijlstra M., Loring J., Jaenisch R., Raulet D. Rejection of class I MHC-deficient hemopoietic cells by irradiated MHC-matched mice. Nature. 349:1991;329-331.